Great Bay Bio Ltd. is an acclaimed high-tech company that focuses on creating blue ocean biopharmaceuticals using digital platforms. With a long history of biomedical research and development, the company has extensive experience in product development. In line with the national strategy of scientific and technological innovation and the coordinated development of the Greater Bay Area, Dawan Biotechnology combines resources from Europe, the United States, Singapore, and Hong Kong to construct a biopharmaceutical platform based on AI technology, big data, and Internet of Things technology. This platform expedites the drug development timeline, reduces development costs, and provides a competitive edge for the industry.